146 related articles for article (PubMed ID: 27245339)
1. Formoterol decreases muscle wasting as well as inflammation in the rat model of rheumatoid arthritis.
Gómez-SanMiguel AB; Gomez-Moreira C; Nieto-Bona MP; Fernández-Galaz C; Villanúa MÁ; Martín AI; López-Calderón A
Am J Physiol Endocrinol Metab; 2016 Jun; 310(11):E925-37. PubMed ID: 27245339
[TBL] [Abstract][Full Text] [Related]
2. Melanocortin-4 receptor agonist (RO27-3225) ameliorates soleus but not gastrocnemius atrophy in arthritic rats.
Gomez-Sanmiguel AB; Nieto-Bona MP; Fernandez-Galaz C; Priego T; Martin AI; Lopez-Calderon A
J Physiol Pharmacol; 2017 Apr; 68(2):191-199. PubMed ID: 28614768
[TBL] [Abstract][Full Text] [Related]
3. Formoterol treatment prevents the effects of endotoxin on muscle TNF/NF-kB, Akt/mTOR, and proteolytic pathways in a rat model. Role of IGF-I and miRNA 29b.
Martín AI; Gómez-SanMiguel AB; Priego T; López-Calderón A
Am J Physiol Endocrinol Metab; 2018 Oct; 315(4):E705-E714. PubMed ID: 29969314
[TBL] [Abstract][Full Text] [Related]
4. Fenofibrate, a PPAR{alpha} agonist, decreases atrogenes and myostatin expression and improves arthritis-induced skeletal muscle atrophy.
Castillero E; Nieto-Bona MP; Fernández-Galaz C; Martín AI; López-Menduiña M; Granado M; Villanúa MA; López-Calderón A
Am J Physiol Endocrinol Metab; 2011 May; 300(5):E790-9. PubMed ID: 21304067
[TBL] [Abstract][Full Text] [Related]
5. Systemic IGF-I administration attenuates the inhibitory effect of chronic arthritis on gastrocnemius mass and decreases atrogin-1 and IGFBP-3.
López-Menduiña M; Martín AI; Castillero E; Villanúa MA; López-Calderón A
Am J Physiol Regul Integr Comp Physiol; 2010 Aug; 299(2):R541-51. PubMed ID: 20519361
[TBL] [Abstract][Full Text] [Related]
6. Eicosapentaenoic acid attenuates arthritis-induced muscle wasting acting on atrogin-1 and on myogenic regulatory factors.
Castillero E; Martín AI; López-Menduiña M; Villanúa MA; López-Calderón A
Am J Physiol Regul Integr Comp Physiol; 2009 Nov; 297(5):R1322-31. PubMed ID: 19741054
[TBL] [Abstract][Full Text] [Related]
7. The melanocortin receptor type 3 agonist d-Trp(8)-γMSH decreases inflammation and muscle wasting in arthritic rats.
Gómez-SanMiguel AB; Martín AI; Nieto-Bona MP; Fernández-Galaz C; Villanúa MÁ; López-Calderón A
J Cachexia Sarcopenia Muscle; 2016 Mar; 7(1):79-89. PubMed ID: 27066320
[TBL] [Abstract][Full Text] [Related]
8. Short-term growth hormone or IGF-I administration improves the IGF-IGFBP system in arthritic rats.
López-Menduiña M; Martín AI; Castillero E; Villanúa MA; López-Calderón A
Growth Horm IGF Res; 2012 Feb; 22(1):22-9. PubMed ID: 22244673
[TBL] [Abstract][Full Text] [Related]
9. Systemic α-melanocyte-stimulating hormone administration decreases arthritis-induced anorexia and muscle wasting.
Gómez-SanMiguel AB; Martín AI; Nieto-Bona MP; Fernández-Galaz C; López-Menduiña M; Villanúa MÁ; López-Calderón A
Am J Physiol Regul Integr Comp Physiol; 2013 May; 304(10):R877-86. PubMed ID: 23515620
[TBL] [Abstract][Full Text] [Related]
10. Effects of the beta
Salazar-Degracia A; Busquets S; Argilés JM; Bargalló-Gispert N; López-Soriano FJ; Barreiro E
Biochimie; 2018 Jun; 149():79-91. PubMed ID: 29654866
[TBL] [Abstract][Full Text] [Related]
11. Experimental arthritis inhibits the insulin-like growth factor-I axis and induces muscle wasting through cyclooxygenase-2 activation.
Granado M; Martín AI; Villanúa MA; López-Calderón A
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1656-65. PubMed ID: 17284570
[TBL] [Abstract][Full Text] [Related]
12. IGF-I system, atrogenes and myogenic regulatory factors in arthritis induced muscle wasting.
Castillero E; Martín AI; López-Menduiña M; Granado M; Villanúa MA; López-Calderón A
Mol Cell Endocrinol; 2009 Oct; 309(1-2):8-16. PubMed ID: 19501629
[TBL] [Abstract][Full Text] [Related]
13. Fenofibrate administration to arthritic rats increases adiponectin and leptin and prevents oxidative muscle wasting.
Castillero E; Martín AI; Nieto-Bona MP; Fernández-Galaz C; López-Menduiña M; Villanúa MÁ; López-Calderón A
Endocr Connect; 2012 Jul; 1(1):1-12. PubMed ID: 23781298
[TBL] [Abstract][Full Text] [Related]
14. Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in response to formoterol administration in rat skeletal muscle.
Joassard OR; Amirouche A; Gallot YS; Desgeorges MM; Castells J; Durieux AC; Berthon P; Freyssenet DG
Int J Biochem Cell Biol; 2013 Nov; 45(11):2444-55. PubMed ID: 23916784
[TBL] [Abstract][Full Text] [Related]
15. Ghrelin receptor agonist GHRP-2 prevents arthritis-induced increase in E3 ubiquitin-ligating enzymes MuRF1 and MAFbx gene expression in skeletal muscle.
Granado M; Priego T; Martín AI; Villanúa MA; López-Calderón A
Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E1007-14. PubMed ID: 16030067
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of the n-3 polyunsaturated fatty acid eicosapentaenoic and fenofibrate on the inhibitory effect of arthritis on IGF1.
Castillero E; López-Menduiña M; Martín AI; Villanúa MÁ; López-Calderón A
J Endocrinol; 2011 Sep; 210(3):361-8. PubMed ID: 21715432
[TBL] [Abstract][Full Text] [Related]
17. IGF-I and IGF-I-binding proteins in rats with adjuvant-induced arthritis given recombinant human growth hormone.
Ibañez De Cáceres I; Villanúa MA; Soto L; Martin AI; López-Calderón A
J Endocrinol; 2000 Jun; 165(3):537-44. PubMed ID: 10828837
[TBL] [Abstract][Full Text] [Related]
18. Tumour necrosis factor blockade did not prevent the increase of muscular muscle RING finger-1 and muscle atrophy F-box in arthritic rats.
Granado M; Martín AI; Priego T; López-Calderón A; Villanúa MA
J Endocrinol; 2006 Oct; 191(1):319-26. PubMed ID: 17065414
[TBL] [Abstract][Full Text] [Related]
19. Loss of Ovarian Function Results in Increased Loss of Skeletal Muscle in Arthritic Rats.
Furlanetto Júnior R; Martins FM; Oliveira AA; Nunes PR; Michelin MA; Murta EF; Orsatti FL
Rev Bras Ginecol Obstet; 2016 Feb; 38(2):56-64. PubMed ID: 26883860
[TBL] [Abstract][Full Text] [Related]
20. Muscle wasting in collagen-induced arthritis and disuse atrophy.
de Oliveira Nunes Teixeira V; Filippin LI; Viacava PR; de Oliveira PG; Xavier RM
Exp Biol Med (Maywood); 2013 Dec; 238(12):1421-30. PubMed ID: 24186267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
